Vanda Pharmaceuticals

Filed a patent for "methods of treatment with tradipitant" on Wed, December 21, 2022

Filed a patent for "methods of treatment with tradipitant" on Wed, December 21, 2022

Filed a patent for "method of treatment with iloperidone" on Fri, June 2, 2023

Filed a patent for "method of treatment" on Mon, December 19, 2022

Filed a patent for "method of treatment" on Fri, June 2, 2023

Filed a patent for "method of treatment" on Thu, October 17, 2024

Filed a patent for "highly purified pharmaceutical grade tasimelteon" on Thu, October 10, 2024

Filed a patent for "melatonin agonist treatment" on Thu, October 3, 2024

Filed a patent for "use of tradipitant in motion sickness" on Mon, March 6, 2023

Filed a patent for "improved use of tradipitant in motion sickness" on Thu, September 12, 2024

Filed a patent for "use of tradipitant in motion sickness" on Thu, August 29, 2024

Filed a patent for "method of treatment" on Thu, September 5, 2024

Filed a patent for "antisense oligonucleotide (aso) gene inhibition and treatment" on Thu, January 11, 2024

Filed a patent for "treatment of disorders with tasimelteon" on Thu, July 11, 2024

Filed a patent for "sleep or post-sleep performance" on Thu, July 11, 2024

Filed a patent for "depot administration of iloperidone" on Thu, August 1, 2024

Filed a patent for "methods of slowing brain volume loss" on Thu, April 20, 2023

Filed a patent for "methods of treating multiple sclerosis" on Thu, May 11, 2023

Filed a patent for "methods of treating multiple sclerosis" on Thu, April 13, 2023

Filed a patent for "methods of treating multiple sclerosis" on Thu, May 11, 2023

Filed a patent for "methods of treating multiple sclerosis" on Thu, April 13, 2023

Filed a patent for "dosing regimen for a selective s1p1 receptor agonist" on Thu, April 27, 2023

Filed a patent for "treatment of atopic dermatitis with tradipitant" on Thu, March 9, 2023

Filed a patent for "treatment of acute anxiety with an alpha-7 nicotinic acetylcholine receptor modulator" on Fri, December 2, 2022

Filed a patent for "highly purified pharmaceutical grade tasimelteon" on Thu, May 18, 2023